NCT02373371 2025-07-29
Actinic Keratoses Treatment With Metvix® in Combination With Light
University Hospital, Limoges
Phase 3 Completed
Clinical Trials
5 trialsNCT00472459 2025-04-18
Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer
Galderma R&D
Phase 3 Completed
NCT00472108 2024-08-05
Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma
Galderma R&D
Phase 3 Completed
NCT01966120 2023-07-28
Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)
Biofrontera Bioscience GmbH
Phase 3 Completed
NCT00926952 2011-09-09
Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion
Innovaderm Research Inc.
Phase 3 Completed